secwatch.observer — SEC 8-K summary
======================================

Issuer:     LivaNova PLC (LIVN)
CIK:        0001639691
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001639691-23-000043
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LivaNova Q1 revenue up 9.7% to $263M, EPS $0.14, raises 2023 guidance; names interim CEO
--------------------------------------------------------------------------------

- Revenue $263.4M, +9.7% reported (+12.7% constant currency) vs. prior year.
- GAAP diluted EPS $0.14; adjusted diluted EPS $0.43.
- Received FDA 510(k) clearance for Essenz heart-lung machine.
- Randomized 500th unipolar depression patient in RECOVER study.
- Bill Kozy appointed interim CEO after Damien McDonald's resignation; full-year 2023 guidance raised.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1639691/000163969123000043/0001639691-23-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1639691/000163969123000043/livn-20230503.htm
  HTML page:      https://secwatch.observer/filing/0001639691-23-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer